Randomised controlled trial of the short-term effects of OROS-methylphenidate on ADHD symptoms and behavioural outcomes in young male prisoners with attention-deficit/hyperactivity disorder (CIAO-II)

Randomised controlled trial of the short-term effects of OROS-methylphenidate on ADHD symptoms and behavioural outcomes in young male prisoners with attention-deficit/hyperactivity disorder (CIAO-II)

Abstract Background Attention-deficit/hyperactivity disorder (ADHD) is a highly prevalent disorder, seen in 20–30% of young adult prisoners. Pharmacoepidemiological studies, a small randomised controlled trial and open trial data of methylphenidate suggest clinically significant reductions in ADHD s...

Full description

Bibliographic Details
Main Authors: Philip Asherson, Lena Johansson, Rachel Holland, Tom Fahy, Andrew Forester, Sheila Howitt, Stephen Lawrie, John Strang, Susan Young, Sabine Landau, Lindsay Thomson
Format: Article
Language:English
Published: BMC 2019-12-01
Series:Trials
Subjects:
Neurodevelopmental disorder
ADHD
OROS-methylphenidate
Prison mental health
Trial
Online Access:https://doi.org/10.1186/s13063-019-3705-9

Internet

https://doi.org/10.1186/s13063-019-3705-9

Similar Items